An allosteric inhibitor of Mycobacterium tuberculosis ArgJ: Implications to a novel combinatorial therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An allosteric inhibitor of Mycobacterium tuberculosis ArgJ: Implications to a novel combinatorial therapy

Published:2018-02-26 Issue:4 Volume:10 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Mishra Archita¹^ORCID,Mamidi Ashalatha S¹,Rajmani Raju S²,Ray Ananya¹,Roy Rajanya¹,Surolia Avadhesha¹^ORCID

Affiliation:

1. Molecular Biophysics Unit Indian Institute of Science Bangalore India

2. Microbiology and Cell Biology CIDR Indian Institute of Science Bangalore India

Funder

Department of Science and Technology, Government of Kerala

Indian Council of Medical Research

Department of Biotechnology, Government of West Bengal

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201708038

Reference43 articles.

1. Bim is a crucial regulator of apoptosis induced by Mycobacterium tuberculosis

2. Impact of pharmacokinetics and pharmacogenetics on the efficacy of pranlukast in Japanese asthmatics

3. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma

4. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?;Behar SM;Nat Rev Microbiol,2010

5. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery;Pharmaceutics;2024-05-28

2. Antimycobacterial and healing effects of Pranlukast against MTB infection and pathogenesis in a preclinical mouse model of tuberculosis;Frontiers in Immunology;2024-05-02

3. New insight into arginine and tryptophan metabolism in macrophage activation during tuberculosis;Frontiers in Immunology;2024-04-02

4. Benzopyrone, a privileged scaffold in drug discovery: An overview of FDA‐approved drugs and clinical candidates;Medicinal Research Reviews;2024-03-26

5. Metabolic Rewiring of Mycobacterium tuberculosis upon Drug Treatment and Antibiotics Resistance;Metabolites;2024-01-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3